Results

Total Results: 948 records

Showing results for "developed".

501. Screening for Colorectal Cancer: Clinical Summary (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qSyg242Cz-X9DDwZg6GEhP
     Screening for Colorectal Cancer: Clinical Summary SCREENING FOR COLORECTAL CANCER CLINICAL SUMMARY OF U.S. PREVENTIVE TASK FORCE RECOMMENDATION Population Adults Age 50 to 75* Adults Age 76 to 85 years* Adults Older than 85* Screen with high sensitivity fecal occult blood testing (FOBT), …

502. Screening for Asymptomatic Bacteriuria in Adults: Clinical Summary of a U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/wDCLf8QzfbRMDsTFEaGD-7
     Screening for Asymptomatic Bacteriuria in Adults: Clinical Summary of a U.S. Preventive Services Task Force Recommendation Statement Figure. Screening for asymptomatic bacteriuria in adults: clinical summary of a U.S. Preventive Services Task Force (USPSTF) recommendation. Screening for Asymptomatic Bacteriuria in A…

503. High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2013%20(4).pdf
     November 01, 2013 - High-Priority Evidence Gaps for Clinical Preventive Services HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES : THIRD ANNUAL REPORT TO CONGRESS NOVEMBER 2013 SUBMITTED BY Dr. Virginia Moyer, Chair Dr. Michael LeFevre, Vice Chair Dr. Albert Siu, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE SE…

504. Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6WFgDkD6kVsynLyYYMPVKk
     Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation Population Pregnant Women Who Have Not Previously Been Diagnosed With Diabetes Re…

505. Procedure Manual Appendix IX. Factors to Consider When Recommending Starting and Stopping Times for Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-ix-factors-consider-when-recommending-starting-and-stopping-times-screening
     July 01, 2017 - Procedure Manual Appendix IX. Factors to Consider When Recommending Starting and Stopping Times for Screening Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence regarding the following factors should be considered wh…

506. Archived: Final Evidence Review: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review49/hepatitis-c-screening-2013
     November 15, 2012 - Methods Scope We developed … The protocol was developed using a standardized process with input from experts and the public.

507. Archived: Final Evidence Summary: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary12/cervical-cancer-screening-2012
     October 18, 2011 - studies that compared LBC or HPV-enhanced primary screening with conventional cytology in countries with developed … effect of verification bias; and were conducted in routine screening populations in countries with developed … Test Performance of Primary Screening With HPV Test Alone and Combination HPV and Cytology Testing in Developed

508. 75Ftpgw4Rz-3Tdmqpstvdg (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/75ftPGW4rZ-3tdMQPstvDg
     August 01, 2012 - Since the 1996 rec- ommendation, the USPSTF has developed and adapted its methods, the framework for … Several tools have been developed that use combina- tions of risk factors to predict falls.

509. Archived: Screening: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/-screening-evidence-summary/gestational-diabetes-mellitus-screening-january-2014
     May 15, 2013 - The key question for this review was developed … The studies confirmed GDM by using criteria developed by Carpenter and Coustan, ADA (endorsed from 2000

510. Screening for Gestational Diabetes Mellitus: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zuBMgkDP5VuWPPQCpfcSey
     Screening for Gestational Diabetes Mellitus: Clinical Summary of USPSTF Recommendation SCREENING FOR GESTATIONAL DIABETES MELLITUS CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic pregnant women after 24 weeks of gestation Asymptomatic pregnant women before 24 we…

511. Medications for Risk Reduction of Primary Breast Cancer in Women: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/eUBUXRUJHua5Q44j_THFn2
     Medications for Risk Reduction of Primary Breast Cancer in Women: Clinical Summary of USPSTF Recommendation MEDICATIONS FOR RISK REDUCTION OF PRIMARY BREAST CANCER IN WOMEN CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic women aged ≥35 years without a prior diagn…

512. Screening for Ovarian Cancer: Evidence Update for the USPTF Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/fNXdu3HGvWE-ovsuhNeANW
     April 01, 2012 - METHODS The USPSTF developed two key questions to be addressed: 1) What are the benefits of screening

513. Archived: Skin Cancer: Counseling, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-counseling-2003
     October 06, 2003 - An unblinded randomized trial showed children at high risk for skin cancers who used sunscreen developed

514. Recommendation: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication
     January 29, 2019 - It is currently unknown whether Neisseria gonorrhoeae has developed resistance to erythromycin ointment

515. High-Priority Evidence Gaps For Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/rtc2016rev_2%20(3).pdf
     December 01, 2016 - High-Priority Evidence Gaps For Clinical Preventive Services DECEMBER 2016 High-Priority Evidence Gaps For Clinical Preventive Services SUBMITTED BY: Dr. Kirsten Bibbins-Domingo, Chair Dr. David C. Grossman, Vice Chair Dr. Susan J. Curry, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE SERVICES TASK FORCE SIXTH AN…

516. Archived: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening-2013
     June 15, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Hepatitis C: Screening June 15, 2013 Recommendations made by the USPSTF are independent of the U.S. government. They should n…

517. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - The USPSTF developed these estimates assuming that aspirin users are not taking NSAIDs and do not have

518. Archived: Final Research Plan: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan16/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
     August 15, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening August 15, 2013 Recommendations made by the USPSTF are independent of the U.S. …

519. Archived: Final Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review52/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication-2011
     July 15, 2011 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Review Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication July 15, 2011 Recommendations made by the USPSTF are indepe…

520. U.S. Preventive Services Task Force Announces Addition of Two New Members (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/two-new-tf-members-announcement-bulletin.pdf
     January 16, 2025 - U.S. Preventive Services Task Force Announces Addition of Two New Members 1 U.S. Preventive Services Task Force Announces Addition of Two New Members Experts in primary care, evidence-based medicine, and health disparities join the Task Force WASHINGTON, D.C. – January 16, 2025 – The U.S. Preventive Services …